Publication: 761

Publication: 761

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: analysis of an intergroup trial (CALGB 9011).

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Leuk Lymphoma vol 54 (2) 252-4

Year:: 2013
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 2

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:
Grants:: U10CA031946 (Bertagnolli), U10CA033601 (Sargent), U10CA032102 (Baker), U10CA021115 , U10 CA180821, U10 CA180882

Corr. Author:
Authors:: Melhem Solh Kanti R Rai Bercedis L Peterson Jonathan E Kolitz Frederick R Appelbaum Martin S Tallman Andrew Belch Richard A Larson Vicki A Morrison

Networks:

Study: CALGB-9011
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: Adult, Aged, Antineoplastic Agents, Cell Transformation, Neoplastic, Female, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Male, Middle Aged, Neoplasm Staging, Treatment Outcome, Vidarabine